BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 19, 2017
View Archived Issues
Animal model mimics social exclusion in depression
Read More
Aravax initiates clinical trials of PVX-108 to treat peanut allergy
Read More
BioAtla and Sinobioway expand CAB antibody collaboration
Read More
Pfizer initiates first-in-human study of PF-06667272
Read More
Amphivena initiates phase I trial of AMV-564 for AML
Read More
CHMP adopts negative opinion for masitinib in indolent systemic mastocytosis
Read More
FDA awards fast track designation to Sage Therapeutics' SAGE-217
Read More
Novel Zika VLP vaccine demonstrates enhanced efficacy in vivo
Read More
Albireo Pharma reveals phase III program for A-4250
Read More
ObsEva completes phase I drug-drug interaction study with OBE-022
Read More
HSV-1716 is safe and shows evidence of immune response and viral replication in phase I study
Read More
Roche divulges novel compounds for treating influenza
Read More
Esteve presents new sigma1-receptor ligands
Read More
SIWA Therapeutics provides update on SIWA-318 monoclonal antibody
Read More
Cinfa reports promising topline data on biosimilar pegfilgrastim
Read More
Noxxon signs clinical trial agreement for evaluation of NOX-A12 in combination with pembrolizumab
Read More
Pfizer's Xalkori approved for new indication in Japan
Read More
Thermo Fisher Scientific partners with Agios to develop ivosidenib companion diagnostic
Read More
Symic reports topline results from phase I/IIa study of SB-061 for osteoarthritis of the knee
Read More
Nuclear receptor ROR-gamma T inhibitor VPR-254 shows promise in colitis model
Read More
Amgen submits BLA for erenumab
Read More
FDA approves Keytruda for certain patients with locally advanced or metastatic urothelial carcinoma
Read More
mGlu5 receptor levels linked to post-traumatic stress disorder
Read More
Abide Therapeutics presents new preclinical and clinical data on ABX-1431
Read More
EMA committee hands down positive opinion on Veltassa for treatment of hyperkalemia
Read More
WHO prepares to deploy Ebola vaccine in latest outbreak
Read More
